semaglutide patent expiry india India just opened the floodgates for “Ozempic-like” drugs. With the patent expiry of Semaglutide, what was once expensive and out of reach is now becoming far more accessible across the country. A

Berberine Dubbed 'Nature's Ozempic' on Social MediaBut Is the Supplement Safe? A newly published case series reports that GLP 1 receptor agonists (like semaglutide and tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or Can Semaglutide Help in Psychiatry Too? Research Shows Promise for AD and PD Psychiatric Times Semaglutide vs. Tirzepatide: What's the Difference? Semaglutide and tirzepatide are powerful, FDA approved tools for managing weight and blood sugar but they work a little differently, and understanding those differences can